AU769241B2 - Bifurcated stent and method for the manufacture of same - Google Patents

Bifurcated stent and method for the manufacture of same

Info

Publication number
AU769241B2
AU769241B2 AU71701/00A AU7170100A AU769241B2 AU 769241 B2 AU769241 B2 AU 769241B2 AU 71701/00 A AU71701/00 A AU 71701/00A AU 7170100 A AU7170100 A AU 7170100A AU 769241 B2 AU769241 B2 AU 769241B2
Authority
AU
Australia
Prior art keywords
stent
section
stent section
defined
bifurcated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU71701/00A
Other versions
AU7170100A (en
Inventor
Ian M. Penn
Donald R. Ricci
George A. Shukov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
evYsio Medical Devices ULC
Original Assignee
Divysio Solutions ULC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2175720 priority Critical
Priority claimed from AU23773/97A external-priority patent/AU2377397A/en
Priority to AU23773/97A priority patent/AU2377397A/en
Application filed by Divysio Solutions ULC filed Critical Divysio Solutions ULC
Publication of AU7170100A publication Critical patent/AU7170100A/en
Assigned to EVYSIO MEDICAL DEVICES INC. reassignment EVYSIO MEDICAL DEVICES INC. Amend patent request/document other than specification (104) Assignors: DIVYSIO SOLUTIONS ULC
Publication of AU769241B2 publication Critical patent/AU769241B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Application status is Ceased legal-status Critical

Links

Description

Our Ref:7552760 P/00/011 Regulation 3:2

AUSTRALIA

Patents Act 1990

ORIGINAL

COMPLETE SPECIFICATION STANDARD PATENT Applicant(s): Address for Service: Divysie- SeCtie J- ULC 865 West 8th Avenue Vancouver British Columbia V5Z 1L7 Canada DAVIES COLLISON CAVE Patent Trade Mark Attorneys Level 10, 10 Barrack Street SYDNEY NSW 2000 Invention Title: Bifurcated stent and method for the manufacture of same The following statement is a full description of this invention, including the best method of performing it known to me:- 5020 BIFURCATED STENT AND METHOD FOR THE MANUFACTURE OF SAME TECHNICAL FIELD The present invention relates to a bifurcated stent and to a method for the manufacture and delivery of a bifurcated stent.

BACKGROUND

ART

Stents are generally known. Indeed, the term "stent" has been used interchangeably with terms such as "intraluminal vascular graft" and "expansible prosthesis". As used throughout this specification the term "stent" is intended to have a broad meaning and encompasses any expandable prosthetic device for implantation in a body passageway a lumen or artery).

In the past six to eight years, the use of stents has attracted an increasing amount of attention due the potential of these devices to be used, in certain cases, as an alternative to surgery. Generally, a stem is used to obtain and maintain the patency of the body passageway while maintaining the integrity of the passageway. As used in this specification, the term "body passageway" is intended to have a broad meaning and encompasses any duct natural or 20 iatrogenic) within the human body and can include a member selected from the group comprising: blood vessels, respiratory ducts, gastrointestinal ducts and the like.

Initial stens were self-expanding, spring-like devices which were inserted in the body passageway in a contracted state. When released, the stent 25 would automatically expand and increase to a final diameter dependent on the size of the stent and the elasticity of the body passageway. Such stents are known in the art as the Wallstent

T

The self-expanding stents were found by some investigators to be deficient since, when deployed, they could place undue, permanent stress on the 30 walls of the body passageway. This lead to the development of various stents which were controllably expandable at the target by passageway so that only target body passageway so that only sufficient force to maintain the patency of the body passageway was applied in expanding the stent.

Generally, in these later systems, a stent, in association with a balloon, is delivered to the target area of the body passageway by a catheter system.

Once the stent has been properly located (the target area of the body passageway can be filled with a contrast medium to facilitate visualization during fluoroscopy), the balloon is expanded thereby expanding the stent, e.g.

by plastic deformation of the stent structure, so that the latter is urged in place against the body passageway. As indicated above, the amount of force applied is at least that necessary to maintain the patency of the body passageway. At this point, the balloon is deflated and withdrawn within the catheter, and subsequently removed. Ideally, the stent will remain in place and maintain the target area of the body passageway substantially free of blockage (or narrowing).

A stent which has gained some notoriety in the art is known as the Palmaz-Schatz" Balloon Expandable Stent (hereinafter referred to as "the Palmaz-Schatz stent"). This stent is discussed in a number of patents including United States patents 4,733,665, 4,739,762, 5,102,417 and 5,316,023, the contents of each of which are hereby incorporated by reference.

20 Another stent which has gained some notoriety in the art is known as Gianrurco-Roubin Flex-StentT (hereinafter referred to as "the Gianturco- Roubin stent"). This stent is discussed in a number of patents including United States patents 4,800,882, 4,907,336 and 5,041,126, the contents of each of which are hereby incorporated by reference.

Other types of stents are disclosed in the following patents: SUnited States patent 5,035,706 (Gianturco et al.), U. nited States patent 5,037,392 (Hillstead), United States patent 5,147,385 (Beck et al.), United States patent 5,282,824 (Gianturco), Canadian patent 1,239,755 (Wallsten), and Canadian patent 1,245,527 (Gianturco et al.), the contents of each of which are hereby incorporated by reference.

All of the stents described in the above-identified patents share the common design of being mono-tubular and thus, are best suited to be delivered and implanted in-line in the body passageway. These known stents are inappropriate for use in a bifurcated body passageway a body passageway comprising a parent passageway that splits into a pair of passageways).

Further, these stents are inappropriate for use in a body passageway having side branches since: accurate placement of the stent substantially increases the risk to the patient, (ii) the risk of passageway closure in the side branches is increased, and (iii) the side branches will be substantially inaccessible.

Indeed the Physician Guide published in support of the Palmaz-Schatz stent states on page 32 (the contents of which are hereby incorporated by reference): no attempt should be made following placement of a PALMAZ-SCHATZ stent to access the side branch with a guide wire or a balloon, as such attempts may result in additional damage to the target vessel or the stent. Attempts to treat obstructed side branches within stented segments can result in balloon entrapment, necessitating emergency bypass surgery." Thus, when installed, the Palmaz-Schatz stent admittedly shields side branches emanating from the target area of the body passageway efctively permanently.

This can be problematic since the only way to treat blockage or other problems associated with the side branches is to perform the type of surgery which installation of the stent was intended to avoid.

This contraindication for conventional mono-tubular stents is corroborated by a number of investigators. See, for example, the following: 1. Ierventional CardiovascularMedicine: Principles and Practice (1994); Publisher: Churchill Livingstone Inc.; pages 221-223 (Ohman et 487-488 (Labinaz et al.), 667-668 (Bashore et al.) and 897 (Bailey et al.), including references cited therein; 2. Giannrco-Roubin Flex-StenTM Coronary Stent: Physician's Guide; page 2, Paragraph 3 under

WARNINGS;

3. Circulation, Vol. 83, No. 1, January 1991 (Schacz et entitled "Clinical Experience With the Palmaz- Schatz Coronary Stent"; pages 148-161 at page 149; and 4. American Heart Journal, Vol. 127, No. 2, February 1994 (Eeckhout et entitled "Complications and follow-up after intracoronary stenting: Critical analysis of a 6-year single-center experience"; pages 262-272 at page 263, the contents of each of which are hereby incorporated by reference Further, some investigators have attempted to install individual stents in each branch of the bifurcated body passageway. However, this approach is fraught with at least two significant problems. First, implantation ofthree individual stents, together with the expansive forces generated upon S.n implantation results in subjecting the central walls of the bifurcated body passageway to undue stress which may lead to post-procedural complications.

Second, since the central walls of the bifurcated body passageway are not ,i supported by the individual stents, this area of the passageway is left substantially unprotected and susceptible to blockage.

su tanialy unprotected and susceptible to blockage.

One particular problem area with bifurcated body passageways is the occurrence of bifurcation lesions within the coronary circulation. Generally, these legions may be classified as follows: TZp Characteristic A Prebranch stenosis not involving the ostium of the side branch; B Postbranch stenosis of the parent vessel not involving the origin of the side branch; C Stenosis encompassing the side branch but not involving the ostium; D Stenosis involving the parent vessel and ostium of the side branch; SE Stenosis involving the ostium of the side branch 20 only; and F Stenosis discretely involving the parent vessel and ostium of the side branch.

See Atlas of nterventional Cardiology (Popma et 1994, pages 77-79, the contents of which are hereby incorporated by reference. The presence of 'bifurcation lesions is predictive of increased procedural complications including acute vessel closure.

Detailed classification of other bifurcated body Passageways is relatively ndeveloped given the lack of n ic t approaches.

undeveloped given the lack of non-surgical treatmen approaches.

United States patent 4,994,071 (MacGregor) discloses a bifurcating! stern apparatus. The particular design incorporates a series of generally parallel oriented loops interconnected by a sequence of "half-birch connections. The lattice structure of the ilustrated stent is constructed of wire. The use of such wire is important to obtain the loop structure Of the illustrated design. The use of a wire loop construction is disadvantageous since it is complicated to manufacture and the resulting stent is subject to expansion variability (e.g.

variable post-expansion distortion and the like).

United States patents 3,993,078 (Bergentz et al.) and 5,342.387 (Summers) also disclose and illustrate a bifurcated scent design constructed of wire. These designs suffer from the same disadvantages as the design described in the previous paragraph.

It would be desirable to have a reliable, -expandable bifurcated stein since this would be useful in treting aneurysms, blockages and other ailments.

It would be further desirable to have a practical method for producing such a scent. It would also be desirable if such a stent was relatively easy to install.

DISC RPup OF THR INVENTION It is an object of the present invention to provide a novel expandable bifurcated steim which obviates or mitigates at least one of the above-mentioned disadvantages of the prior art.

It is another object of the present invention to provide a novel method for the manufacture of an expandable bifurcated stent.

It isaohrobject of the present ine tot provide anovel method for implanting an expandable bifurcated stent.

Acoriglin one of its aspcs the prsn in'venion prvdsan expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a firs intersection, the stern being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways being constructed of a tubular wall having a porous surface, at least one connection portion being disposed at the first intersection for reinforcing the first intersection.

In another of its aspects, the present invention provides expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways having a porous surface, at least one connection portion interconnecting the pair of secondary passageways for reinforcing the first intersection.

In yet another of its aspects, the present invention provides a method for production of a bifurcated sten comprising the step of connecting a first stent section to a second sten section, the first stent section having an end thereof 20 adapted for connection to an opening disposed along the length of a second stent section.

In yet another of its aspects, the present invention provides a method for production of a bifurcated stent comprising the steps of: connecting a first stent section to a second stent section to provide a connection portion; .i (ii) provide an opening in the connection portion; (iii) connecting a third stent section to the connection portion.

In yet another of its aspects, the present invention provides a method for production of a bifurcated stent comprising the steps of: passing a first stent section having a first opening disposed along a length thereof through a second stent section having a second opening disposed .along a length thereof, the first stent section having a diameter less than a diameter of the second stent section; passing a leading end of the first stent section through the second opening of the second stent section; and substantially aligning the first opening and the second opening with respect to one another.

In yet another of its aspects, the present invention provides a method for delivery to a target body passageway of an expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageway being constructed of a tubular wall having a porous surface, the method comprising the steps of: disposing the stent in the first, contracted position on a catheter; inserting the stent and catheter within the target body passageway by catheterization of the target body passageway; exerting a radially outward expansive force on the stent such that the stent assumes the second, expanded position and is urged against the target body passageway.

Thus, an aspect of the present invention relates to the provision of an Sexpandable bifurcated stent constructed of a tubular wall having a porous S. surface. As used throughout this specification, the term "tubular wall", when used in relation to a stent, is intended to mean a substantially cylindrical tube w;hich subsequently has been subjected to an etching by laser, chemical or other suitable means) or similar technique to remove pre-selected portions of he cylindrical tube thereby providing a porous surface on the tube this is distinct from a stent constructed of wire bent to a selected shape/design. To the knowledge of the Applicant's, an expandable bifurcated stent having such a tubular wall has heretofore been unknown.

As used throughout this specification, the term "bifurcated stent" is intended to have a broad meaning and encompasses any stent having a primary passageway to which is connected at least two secondary passageways. Thus trifurcated stents are encompassed herein. Further, one of the secondary passageways can be a continuation of the primary passageway with the result that the other secondary passageway is essentially a side branch to the primary passageway.

The Applicant's have also discovered that various repeating patterns in the porous surface of the tubular wall are particularly advantageous. Generally the repeating pattern is a polygon having a pair of side walls substantially parallel to the longitudinal axis of the stent passageway in question, a first concave-shaped wall and a second convex-shaped wall connecting the side walls. The various repeating patterns which are useful in the context of the present invention are disclosed in the following copending patent applications filed in the name of the assignee of the present invention: Canadian patent application number 2,134,997 (filed November 3, 1994); Canadian patent application number 2,171.047 (filed March 5. 1996).

Canadian patent application number 2,175,722 (filed May 3, 1996); 20 Canadian patent application number 2.185,740 (filed September 17, 1996); International patent application PCT/CA97/00151 (filed March 5, 1997), and International patent application PCT/CA97/00 15 2 (filed March 5, 1997); the contents of each of which are hereby incorporated by reference (hereinafter collectively referred to as the "Divysio patent applications").

The present bifurcated stent may be constructed from any suitable starting material. Preferably, the starting material is a thin tube of a metal or alloy (non-limiting examples include stainless steel, titanium, tantalum, nitinol, Elgiloy, NP35N and mixtures thereof) which would then have sections thereof cut or etched out to leave a repeating pattern, ia .a j, such as one or more of those disclosed in the Divysio patent applications.

The stem of the present invention may further comprise a coating material thereon. The coating material may be disposed continuously or discontinuously on the surface of the stent. Further, the coating may be disposed on the interior and/or the exterior surface(s) of the sten. The coating material may be one or more of a biologically inert material to reduce the thrombogenicity of the stent), a medicinal composition which leaches into the wall of the body passageway after implantation to provide anticoagulant action, to deliver a pharmaceutical to the body passageway and the like) and the like.

The stent is preferably provided with a biocompatible coating, in order to minimize adverse interaction with the walls of the body vessel and/or with the liquid, usually blood, flowing through the vessel. The coating is preferably a polymeric material, which is generally provided by applying to the stent a solution or dispersion of preformed polymer in a solvent and removing the solvent. Non-polymeric coating material may alternatively be used. Suitable coating materials, for instance polymers, may be polytetraflouroethylene or silicone rubbers, or polyurethanes which are known to be biocompatible Preferably, however, the polymer has zwitterionic pendant groups, generally ammonium phosphate ester groups, for instance phosphoryl choline groups or 20 analogues thereof. Examples of suitable polymers are described in published International patent applications WO-A-93/1647 9 and WO-A-93/157 7 Polymers described in those specifications are hemo-compatible as well as generally biocompatible and, in addition, are lubricious. When a biocompatible coating is used, It is important to ensure that the surfaces of the stent are completely coated in order to minimize unfavourable interactions, for instance .:..with blood, which might lead to thrombosis.

SThis good coating can be achieved by suitable selection of coating conditions, such as coating solution viscosity, coating technique and/or solvent removal step.

BRIEF DESCRIPTION OF THE DRAWINGS Embodiments of the present invention will be described with reference to the accompanying drawings wherein like numerals designate like parts and in which: Figure 1 illustrates a side elevation of a bifurcated stent in accordance with the present invention; Figures 2-4 illustrate a first embodiment of a method for production of a bifurcated stent; Figure 5 illustrates a second embodiment of a method for production of a bifurcated stent; Figures 6a and 6b illustrate a post-treatment of a bifurcated stent which has been produced according to the methods illustrated in Figures Figures 7 and 8 illustrate a third embodiment of a method for production of a bifurcated stent; Figure 9 illustrates a post-treated bifurcated stent which has been produced according to the method illustrated in Figures 7 and 8; Figures 10 and 11 illustrate a fourth embodiment of a method for production of a bifurcated stent; •Figure 12 illustrates a cross-section of a bifurcated body passageway 20 into which the a bifurcated stent produced according to the present method of manufacture is being delivered; which the bifurcated stent is positioned in a first, contracted position; Figure 14 illustrates a cross-section of a bifurcated body passageway in which the bifurcated stent is positioned in a second, expanded position; Figures 15 and 16 illustrate a side elevation of another bifurcated stent in accordance with the present invention; Figures 17-22 illustrate various preferred features of the bifurcated stent illustrated in Figures 15 and 16.

u* -12- BEST MODE FOR CARRYING OUT TF INVENTION With reference to Figure 1, there is illustrated a stent 10. Stent comprises a proximal end 15 and a distal end 20. Proximal end 15 comprises a primary passageway 25. Distal end 20 comprises a pair of secondary passageways 30,35. Secondary passageways 30,35 are connected to primary passageway 25 at an intersection point As will be apparent to those of skill in the art, stent 10 incorporates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to incorporate other designs such as those disclosed in the other Divysio patent applications.

With reference to Figures 2-4, an embodiment of the present method for production of a bifurcated stent is illustrated. For ease of illustration, the porous surface of the tubular wall of the stent is not illustrated.

As illustrated, a first stentsection 45 comprises a cylindrical tube having a bevelled cut 50 made adjacent one end of the cylindrical tube. Those of skill in the art will recognize that bevelled cut 50 may be incorporated into first stent section 45 during or after the production of first stent section 45. Specifically, tit is possible to produce first stent section 45 having a pre-selected porous design which includes bevelled cut 50 via a computer programmable high Sprecision laser etching technique. Alternatively, it is possible to use another etching technique to produce first stent section 45 without bevelled cut 50 and thereafter use a precision jig or other means to cut first stent section 45 to produce bevelled cut Similarly, a second stent section 55 is provided and includes radial cuts 56,57 and a longitudinal cut 58. Radial cuts 56.57 and longitudinal cuts 58 may be produced in second stent section 55 in the manner discussed in the previous paragraph with respect to the production of bevelled cut 50 in first stent section Thereafter, a flaportion 51f first tent section 45 is foldedaway from bevelled cut 50. Similarly, a pair of flap 52,53 are folded away from longitudinal cut 58 to expose an opening 54.

First stent section 45 is then lowered to cover opening 54 of second stent section 55. Flaps 52,53 are folded to overlap a portion of first stent section Flap 51 is folded to overlap a portion of second stent section 55. With reference to Figure 4, it is particularly preferred to adapt the geometry of flaps 52,53 of second stent section 55 such that various of the struts disposed in flaps 52,53 overlap with or are juxtaposed (in plan view) along at least a portion of the length thereof with the struts on first stent section 45 (this is illustrated in more detail hereinbelow with reference to Figure 16). Preferably, the degree of such overlap or juxtaposition is sufficient to: facilitate affixing the flaps 52,53 of second stent section to first stent section (ii) achieve uniform expansion of the stent junction without occurrence of substantial distortion; and (iii) avoid the occurrence of "stent trap" or "stent jail" (usually the result of cracking, buckling or other distortion at the junction of a deployed bifurcated stent making difficult or impossible to deliver a further stent through the stent).

20 S 2 At this point, the flaps may be secured to the respective stent sections V by any suitable means such as spot welding by a laser or other suitable means), loops, clips and the-like. The preferred method of affixing the flaps. to 'the respective stent section is to spot weld them.

25 A particular advantage of the process illustrated in Figures 2-4 is that .tersection point 40 (Figure I overlapping flaps not illustrated for clarity) of the resulting stent is reinforced by virtue of disposition of the flaps overlapping a portion of the respective stent sections.

As will be apparent to those of skill in s w b to those of skill in the art, in certain circumstances, it may be possible and even desirable to reduce the size of or even eliminate flap 51. Further, in certain circumstances, it may be possible or ever desirable "Wt,6.r7.«* -14to trim one or both of flaps 52,53 prior to connection of first stent section to second stent section With reference to Figure 5, there is illustrated another embodiment of the present method for manufacture of a bifurcated stent. In this embodiment flap 51 (Figures 2 and 3) is simply cut away from first stent section Further, an oval opening 54a is cut into second stent section 55a there are no flaps affixed to second stem section 55a). Stent section 45a is then lowered on and connected to second stent section 55a. First steit section 4 5a and second stent section 55a may be connected to another in the manner described hereinabove with reference to Figure 2-4.

With reference to Figure 6a, there is illustrated the stent produced by the methods illustrated in Figures 2-5. During production of the stent, it is desirable to minimize the angle between first stent section 45 and second stent section 55. Even with this effort, it is prferred that the adjacent termini of first stent section 45 and section sten section 55 are subjected to application of gentle squeezing or other sufficient force in the direction of arrows A to facilitate catheterization of the stent. The result f such st-roduction treatment of the stent is illustrated in Figure 6b.

With reference to Figures 7 and 8, there is illustrated yet another 20 embodiment of the present method for manufacture of a bifurcated stet. In this embodiment, a pair of first stent sections 45b re secured or affixed to one another. secured or affixed to one anot. Thereafter, an apex portion 46b of the resulting construction is removed exposing an opening 54b. A second stent section 55b is then connected to opening 54b provided by th e combination of first stent sections 45b. The manner of securing second stent section 55b to the periphery of opening 54b created by first stent sections 45b is not particularly restricted and may be effected as discussed hereinabove. As will be appreciated by those of skill in the art, it is possible and, in certain circumstances desirable, to have one or more flaps on one or move of first stent sections 45b and second stent section 55b. Such flaps would be used in the manner discussed hereinabove in respect of Figures 2-4 to overlap a portion of the opposite stent section.

With reference to Figure 9, there is illustrated the stent produced according to the method illustrated in Figures 7 and 8 after post-treatment in the manner discussed above in respect of Figures 6a and 6b. That is. first stent sections 45b are subjected to application of gentle squeezing or other sufficient force in the direction of arrows B to facilitate catheterization of the stent.

With reference to Figures 10 and 11, there is illustrated yet another embodiment of the present method for manufacture of a bifurcated stem. In this embodiment, a first stent section 45c is provided with an opening 54c. A second stent section 55c is provided with an opening 56c. Second stent section 55c has a diameter slightly less than that of first stent section 4 5c. The difference in diameter between first stent section 45c and second stent section is sufficient to enable coaxial movement of the stent sections with respect to one another with causing damage to either stent section.

As illustrated by arrow C in Figure 10, the end of second stent section 55c is coaxially fed into an end of first sten section 45c. Once the leading end of second stent section 55c reaches opening 54c of first stent section 45c, it is pulled through opening 54c as illustrated by arrow D in Figure 10. Second stent section 55c is pulled through opening 54c until opening 56c is aligned with opening 54c this is illustrated by dashed oval E in Figure 11.

20 When practising the method illustrated in Figures 10 and 11, care should be taken to design openings 54c and 56c so that they are in alignment when the trailing end of second stent section 55c is flush with the trailing end of first stent section 45c. Further, region F (Figure 11) of the resulting bifurcated stent Sis "double reinforced" since it contains a coaxial disposition of first stent section 45c and second stent section 55c. Accordingly, it is possible and, in some cases even desirable, to modify the design of the respective stent sections in this region so that the overall expansion and relative flexibility/rigidity of the stent in this region is commensurate with that of the remaining portion of the stent the secondary passageways which branch off from region F in Figure 11).

While the embodiment illustrated in Figures 10 and 11 illustrates the resultant bifurcated stent having a coaxial, overlapping arrangement of stent sections flush at one end, it will be appreciated by those of skill in the art that the length of first stent section 45c or second stent section 55c may be shortened thereby minimizing the size of region F in Figure 11.

With reference to Figures 12-14, there is illustrated a bifurcated body passageway 150 comprised of a proximal passageway 155 and a pair of distal passageways 160,165. As illustrated, bifurcated body passageway 150 comprises a Type Bifurcation lesion having characteristic blockages 170,175,180.

Stent 10 is delivered to bifurcated body passageway 150 in the following manner. Initially, a pair of guidewires 185,190 are inserted into proximal passageway 155 such that guidewire 185 enters distal passageway 160 and guidewire 190 enters distal passageway 165. The manner by which the guidewires are inserted is conventional and within the purview of a person skilled in the art.

As illustrated, stent 10 is positioned in association with a pair of catheters 195,200 (for clarity, the interior of stent 10 is not shown).

Catheter 195 has associated with it a balloon 205. Catheter 200 has associated with it a balloon 210. Balloons 205.210 substantially fill primary passageway 25 of stent 10. Balloon 205 substantially fills secondary 20 passageway 30 of stent 10. Balloon 210 substantially fills secondary Spassageway 35 of stent 10.

The stent/catheter/balloon combination is delivered through proximal 060 .passageway 155 with the aid of guidewires 185,190. As the stent/catheter/balloon combination approaches distal passageways 160,165, predisposition of guidewires 185,190 serves to separate secondary passageways 30,35 to be disposed in distal passageways 160,165, respectively. Thus, as illustrated in Figure 13, stent 10 is positioned in place.

Once stent 10 is in position, balloons 205,210 are expanded resulting in 0.0 implantation of stent 10 in the corresponding interior surfaces of proximal passageway 155 and distal passageways 160,165. Upon implantation of stent balloons 205,210 are collapsed. Thereafter, catheters 195,200 and guidewires 185,190 have been removed leaving the implanted stent 10 shown in Figure 14. As illustrated in Figure 14, blockages 170.175,180 are bulged radially outwardly in combination with the appropriate portions of proximal passageway 155 and distal passageways 160,165 resulting in a reduction in the overall blockage in bifurcated body passage 150.

It will be apparent to those of skill in the art that implantation of stent can be accomplished by various other means. For example, it is contemplated that it is possible to substitute the pair of catheter/balloon combinations illustrated in Figures 12 and 13 with a single, bifurcated catheter/balloon design which mimics the design of the stent. Thus, in this modification, the balloon and guidewire would be design to mimic the bifurcated design of the stent. As further alternative, it is contemplated that the stent can be made of a suitable material which will expand when bifurcated body passageway 150 is flushed with a liquid having an elevated temperature 150*F-160*F). Further, stent 10 can be designed to expand upon the application of mechanical forces other than those applied by a balloon/catheter. Still further, stent 10 can be S designed self-expanding by constructing stent from material such as nitinol :""and the like) to be implanted as described above. In this embodiment, the radially outward force exerted on the stent would be generated within the stent itself.

With reference to Figures 15-22. there is illustrated another preferred bifurcated stent in accordance with the present invention. As will be apparent to those of skill in the art, the stent illustrated in Figures 15-22 shares many of o the features of stent 10 illustrated in Figure 1.

Thus, with reference to Figures 15 and 16, there is illustrated a stent 100. Figure 15 is a side elevation of stent 100 without the porous surface illustrated (for clarity). Figure 16 is a side elevation of an enlarged portion of stent 100 with the porous surface illustrated. Stent 100 comprises a proximal end 102 and a distal end 104. Proximal end 102 comprises a primary passageway 103. Distal end 104 comprises a pair of secondary passageways 105,106. Secondary passageways 105.106 are connected to primary -18passageway 103 at an intersection point 107 the nature of intersection point 107 will be further discussed hereinbelow. It is intersection point 107 which distinguishes stent 100 in Figure 16 from stent 10 in Figure 1.

As will be apparent to those of skill in the art, sten 100 incorporates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to incorporate other designs such as those disclosed in the other Divysio patent applications.

With reference to Figures 17-19, manufacture of stent 100 will be discussed. Generally, the manufacture of stent 100 is similar to the manufacture of stent 10 illustrated in Figures 1-4 and discussed hereinabove.

The principle difference in the manufacture of stent 100 is the use of a modified first stent section 108.

First stent section 108 is constructed from a substantially cylindrical tube 109. A porous surface 110 is disposed on a major portion of cylindrical tube 109. A first connection tab 111 and a second connection tab 112 are also disposed on cylindrical tube 109. As discussed hereinabove, it is possible to produce first section 108 comprising porous 110, first connection tab 111 and second connection tab 112 using computer programmable, high precision laser etching techniques or by other etching techniques in combination with precision jig techniques. This results in an end of porous surface 110 comprising first connection tab 111, second connection tab 112 and a bevelled edge 113. The product of the cutting techniques is illustrated in Figure 18.

Figure 19 is an enlarged perspective view of a portion of first connection tab 111 (second connection tab 112 is preferably the same). As illustrated, first S. connection tab 111 comprises a stem 114 and a head 115. Preferably, stem 114 and/or head 115 are curved to have a shape complementary to the outer surface of the second section to which first stent section 108 is connected (discussed in more detailed hereinbelow). Stem 114 and head 115 comprise a plurality of slots 116 disposed therein. Slots 116 may be disposed in stem 114 and head 115 by the use of a computer programmable, high precision laser as described -19above. Preferably, slots 116 are disposed throughout the thickness of stem 114 and head 115. Slots 116 may be may have a straight or tapered cross-section.

Preferably, slots 116 have a thickness in the range of from about 0.0015 to about 0.004 inches. Head 115 further comprises solid slot-free or nonporous) regions 117,118.

Thus, in the embodiment illustrated in Figure 19, slots 116 serve to from a porous surface in first connection tab 111 (second connection tab 112 is preferably the same). While it is preferred to have such a porous surface disposed in the connection tabs, the precise nature of the porosity is not particularly restricted. The provision of a porous surface, particularly at head 115, facilitates expansion of the connection tab while minimizing or avoiding the occurrence of cracking or distortion.

After the production of first stent section 108, first connection tab 111 and second connection tab 112 are bent or otherwise moved to be substantially collinear with the periphery of bevelled edge 113 as illustrated in Figure 118). At this point, first stent section 108 may be connected to another stent p section of a design similar to second stent section 55 discussed hereinabove with reference to Figures 24 see intersection point 107 in Figure 16. In this embodiment, as in the embodiments illustrated in Figures 2-4, it is preferred to adapt the geometry of flaps 52,53 of second stent section 55 such that various of the struts disposed in flaps 52.53 overlap along at a portion of the length S. thereof with the struts on first stent section 108. See. for example, regions

G

and H in Figure 16 which illustrates an embodiment of such partial overlap and juxtaposition (in plan view). First connection tab 111 and second connection tab 112 may be secured to the second stent section as described above.

Specifically, it is particularly preferred to connect solid non-porous) regions 117,118 to the stent section portion.

The benefits accruing from the use of first stent section 108 in the production a bifurcated stent include: 1. The provision of at least one solid non-porous) region in the connection tabs facilitates attachment of the.

respective stent sections to one another laser welding is facilitated significantly); 2. The provision of a porous surface in at least a portion of the connection tabs facilitates bending thereof for connection of the respective stent sections; and 3. The provision of slots 116, particularly in second connection tab 112 (see Figure 15), allows the slots to function as a solid state valve at the "crotch" of the bifurcated stent thereby providing sealed, reinforcement of the bifurcated stent in this crucial region this is illustrated in Figure 20 which depicts tapered openings for slots 116 in the apex of the bend in stem 114.

Figure 21 illustrates an alternate embodiment of the embodiment Sillustrated in Figures 15-20. Specifically, in Figure 21, second stent section otherwise the same as that described hereinabove with reference to Figures 1-4, is adapted to include a landing 119 for receiving a solid non-slot or non- "porous) connection tab 120. Landing 119 may be connected to connection tab 120 as described hereinabove.

i With reference to Figure 22, there is illustrated a variant to the embodiment illustrated in Figure 21. Specifically, in Figure 22, a connection Stab 121 having the entire surface thereof slotted and otherwise porous is connected to landing 119.

While this invention has been described with reference to illustrative embodiments, this description is not intended to be construed in a limiting sense. Various modifications of the illustrative embodiments, as well as other embodiments of the invention, will be apparent to persons skilled in the art -21upon reference to this description. For example, while first connection tab 111 and second connection tab 112 have been illustrated as being attached to first stem portion 108, it is possible to have these tabs integral with second stent portion 55. Alternatively, the connection tabs do not have to integral with either of the stent portions and, instead, can be custom-designed, independent connection tabs which are affixed to both stent portions. Still further, it is possible for the connection tabs (integral or independent) to have a different thickness than either of the stent sections. It is therefore contemplated that the appended claims will cover any such modifications or embodiments.

Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.

The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement or any form of suggestion that that prior art forms part of the common general acknowledge in Australia.

Claims (32)

1. An expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways being constructed of a tubular wall in the form of a substantially cylindrical tube having preselected portions thereof removed to define a porous surface, at least one connection portion being disposed at the first intersection for reinforcing the first intersection.
2. The bifurcated stent defined in claim 1, wherein the stent comprises a first stent .section connected to a second stent section. 0. The bifurcated stent defined in claim 2, wherein an end of the first stent section is connected to an opening disposed along a length of the second stent section.
4. The bifurcated stent defined in claim 3, wherein a first connection portion is disposed at an end of the first stent section and is connect to the second stent section.
5. The bifurcated stent defined in claim 4, wherein the first connection portion is integral with an end of the first stent section.
6. The bifurcated stent defined in claim 4, wherein the first connection portion comprises a porous section and a non-porous section, the non-porous section connected to the second stent section.
7. The bifurcated stent defined in claim 6, wherein the porous section comprises a P:\WPDOCS\dys\specic\7552760spc.doc-29/12/00 -23- plurality of elongate slots.
8. The bifurcated stent defined in claim 7, wherein the elongate slots traverse the thickness of the at least one connection tab.
9. The bifurcated stent defined in claim 7, wherein the elongate slots are disposed substantially orthogonal to a longitudinal axis of the first stent section. The bifurcated stent defined in claim 1, wherein the second stent section comprises 10 a second connection portion along at least a portion of the periphery of the opening, the second connection portion connected to the first stent section.
11. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are coaxially disposed with respect to one another along at 15 least a portion of the primary passageway.
12. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are coaxially disposed with respect to one another along substantially the entire length of the primary passageway.
13. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are connected to one another and to a third stent section, at least one of the stent sections comprising the primary passageway and each of the other to stent sections comprising a secondary passageway.
14. The bifurcated stent defined in claim 1, wherein the at least one connection portion interconnects the pair of secondary passageways. The bifurcated stent defined in claim 1, wherein the at least one connection portion connects one of the pair of second passageways to the primary passageway. P:\\PDOCS\dy scci\7552760sc.doc-2912/ 24
16. A method for production of a bifurcated stent comprising the step of connecting a first stent section to a second stent section, the first stent section having an end thereof adapted for connection to an opening disposed along the length of a second stent section; the first stent section and the second stent section being constructed of a tubular wall in the form of a substantially cylindrical tube having preselected portions thereof removed to define a porous surface.
17. The method defined in claim 16, wherein the end of the first stent section adapted for connection is bevelled with respect to a longitudinal axis of the first stent ooooo3 S 10 section. ego• i 18. The method defined in claim 16, comprising the further step of disposing at least one first flap portion at the end of the first stent section adapted for connection to a portion the second stent section.
19. The method defined in claim 18, wherein the at least one flap portion comprises a connection tab having a non-porous surface disposed on at least a portion thereof. o*
20. The method defined in claim 18, wherein the at least one flap portion comprises a S 20 connection tab having a porous surface disposed on at least a portion thereof.
21. The method defined in claim 20, wherein the porous surface comprises a plurality of substantially elongate slots.
22. The method defined in claim 18, wherein the at least one flap portion comprises a connection tab having both a porous surface and non-porous surface disposed thereon.
23. The method defined in claim 22, wherein the porous surface comprises a plurality of substantially elongate slots. P:\WDOCS\dys\sp.,ie\752760W .d~c-29/12/0 25
24. The method defined in claim 18, wherein the at least one first flap portion is produced by folding from the end of the first stent section adjacent the bevelled cut. The method defined in claim 18, wherein, prior to the connecting step, the at least one first flap portion is trimmed to a reduced size.
26. The method defined in claim 18, comprising the further step of overlapping the at least one first flap portion of the first stent section on to a portion of the second stent section.
27. The method defined in claim 26, wherein the connecting step comprises welding •the at least one first flap portion of the first stent section to the second stent section.
28. The method defined in claim 18, wherein, prior to the connecting step, the at least one first flap portion is removed. 9090
29. The method defined in claim 16, comprising the further step of disposing at least one second flap portion at a periphery of the opening disposed along the length of 9 the second stent section. S" o.1
30. The method defined in claim 16, comprising the further step of disposing a pair of second flap portions at a periphery of the opening disposed along the length of the second stent section.
31. The method defined in claim 30, wherein, prior to the connecting step, at least one second flap portion is trimmed to a reduced size.
32. The method defined in claim 30, comprising the further step of overlapping the at least one second flap portion of the second stent section on to a portion of the first stent section. P:\WPDOCS\dysspeci\75276Ospcdoc.29/12/00 -26-
33. The method defined in any one of the preceding claims, wherein the connecting step comprises welding the at least one second flap portion of the second stent section to the first stent section.
34. The method defined in claim 30, wherein, prior to the connecting step, at least one second flap is removed. The method defined in claim 16, comprising the further steps of producing the second stent section by 10 providing a pair of third stent sections, each third stent sections having an end thereof bevelled with respect to a longitudinal axis of the third stent section; joining the pair of third stent sections in a complementary manner at each bevelled end thereof to provide a substantially V-shaped stent section; and removing an apex portion of the V-shaped stent section to define the second stent section having an opening therein.
36. The method defined in claim 35, wherein the connecting step comprises connecting the end of the first stent section to the opening defined in the V-shaped stent *90000 section.
37. The method defined in claim 16, wherein the connecting step comprises welding the first stent section to the second stent section.
38. A method for production of a bifurcated stent comprising the steps of: passing a first stent section having a first opening disposed along a length thereof through a second stent section having a second opening disposed along a length thereof, the first stent section having a diameter less than a diameter of the second stent section; passing a leading end of the first stent section through the second opening of the second stent section; and substantially aligning the first opening and the second opening with respect to one leo LZS:60 ewul :e!leJlsnv dll Aq pa!Aao O 1 g08Z8tP00-11glS :ON 1I SVAOO PAW FIL'. pbi' .tn t pllJ) Aki e a d i t I1/01 -27- another; the first stent section and the second stent section being constructed of a tubular wall in the form of a substantially cylindrical tube having preselected portions thereof removed to define a porous surface. r Dated this 5 t day of November, 2003 EVYSIO MEDICAL DEVICES INC. (FORMERLY DIVYSIO SOLUTIONS ULC) By Its Patent Attorneys DAVIES COLLISON CAVE i 6/S :bd L:68 E/TI/98 6D3 NOSI'03 saWIna 888T Z9Z6 Z T9 hq juas xej
AU71701/00A 1996-05-03 2000-11-20 Bifurcated stent and method for the manufacture of same Ceased AU769241B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2175720 1996-05-03
AU23773/97A AU2377397A (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU23773/97A AU2377397A (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU23773/97A Division AU2377397A (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same

Publications (2)

Publication Number Publication Date
AU7170100A AU7170100A (en) 2001-02-01
AU769241B2 true AU769241B2 (en) 2004-01-22

Family

ID=30773878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71701/00A Ceased AU769241B2 (en) 1996-05-03 2000-11-20 Bifurcated stent and method for the manufacture of same

Country Status (1)

Country Link
AU (1) AU769241B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
WO1996034580A1 (en) * 1995-05-04 1996-11-07 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
WO1996034580A1 (en) * 1995-05-04 1996-11-07 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device

Also Published As

Publication number Publication date
AU7170100A (en) 2001-02-01

Similar Documents

Publication Publication Date Title
US6569193B1 (en) Tapered self-expanding stent
US7060091B2 (en) Stent having variable properties and method of its use
US6368355B1 (en) Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
US5651174A (en) Intravascular radially expandable stent
CA1330186C (en) Expandable intraluminal graft
US5817152A (en) Connected stent apparatus
US6033434A (en) Bifurcated endovascular stent and methods for forming and placing
US7850725B2 (en) Extendible stent apparatus
US6730116B1 (en) Medical device for intraluminal endovascular stenting
US6117165A (en) Expandable intraluminal endoprosthesis
EP1155664B1 (en) A helical stent having flat ends
US6086611A (en) Bifurcated stent
EP1435878B1 (en) System for fixation of endoluminal devices
US5556414A (en) Composite intraluminal graft
AU718869B2 (en) Stent for improved transluminal deployment
CA2386335C (en) Non-foreshortening intraluminal prothesis
CA2708603C (en) Method and apparatus for stenting
US6344055B1 (en) Method for production of an expandable stent
US6695876B1 (en) Endovascular prosthesis
US20080208319A1 (en) Multi-Segment Modular Stent And Methods For Manufacturing Stents
US20010037137A1 (en) Extendible stent apparatus
US6599315B2 (en) Stent and stent delivery assembly and method of use
EP1346706A1 (en) Stent with enhanced crossability
US7892279B2 (en) Extendible stent apparatus
EP1279382A1 (en) Curved stent

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: EVYSIO MEDICAL DEVICES INC.

Free format text: FORMER NAME: DIVYSIO SOLUTIONS ULC

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND APPLICANT S NAME TO READ: EVYSIO MEDICAL DEVICES ULC

FGA Letters patent sealed or granted (standard patent)